PREMATURE OVARIAN FAILURE 13
|
disease |
|
Disease or Syndrome
|
1
|
2
|
0.600 |
None |
1.000 |
1 |
2
|
2017 |
2017 |
PROSTATE CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
5
|
6
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Lupus Erythematosus, Systemic
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
1883
|
1172
|
0.130 |
None |
0.833 |
6 |
1
|
2008 |
2017 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4173
|
1142
|
0.120 |
None |
0.800 |
5 |
2
|
2008 |
2017 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.120 |
None |
0.667 |
3 |
2
|
2016 |
2017 |
Diabetes Mellitus, Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
1675
|
954
|
0.110 |
None |
1.000 |
2 |
2
|
2007 |
2009 |
Rheumatoid Arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
2723
|
2387
|
0.100 |
None |
1.000 |
3 |
10
|
2007 |
2011 |
17 Hydroxyprogesterone measurement
|
phenotype |
|
Laboratory Procedure
|
7
|
19
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.100 |
None |
1.000 |
1 |
2
|
2017 |
2017 |
Myasthenia Gravis
|
disease |
Neoplasms; Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
336
|
93
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Systemic Scleroderma
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
979
|
287
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
C4 complement assay (procedure)
|
phenotype |
|
Laboratory Procedure
|
12
|
15
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Takayasu Arteritis
|
disease |
Skin and Connective Tissue Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
136
|
55
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Adenocarcinoma of lung (disorder)
|
disease |
Neoplasms
|
Neoplastic Process
|
2438
|
563
|
0.100 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
mathematical ability
|
phenotype |
|
Mental Process
|
854
|
2127
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Age at menopause
|
phenotype |
|
Finding
|
129
|
209
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Child Development Disorders, Pervasive
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
168
|
379
|
0.100 |
None |
1.000 |
1 |
2
|
2017 |
2017 |
Ulcerative Colitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1458
|
827
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Age at menarche
|
phenotype |
Behavior and Behavior Mechanisms
|
Finding
|
267
|
591
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Hair Color
|
phenotype |
|
Organism Attribute
|
130
|
312
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Systolic Pressure
|
phenotype |
|
Clinical Attribute
|
843
|
1931
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Intelligence
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental Process
|
645
|
2093
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Oligomenorrhea
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
37
|
1
|
0.100 |
None |
|
0 |
|
|
|